Diabetes care made simpler

t:slim X2 insulin pump with Control-IQ technology

  • Adjusts insulin delivery to help prevent highs and lows
  • Automatically delivers a correction bolus*
  • Features Exercise Activity and Sleep Activity
  • Requires zero fingersticks with Dexcom G6 CGM†
†If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Dexcom G6 CGM sold separately.

92%

Average time Control-IQ technology participants spent in closed-loop over a six-month period.1

97%

Percent of Control-IQ technology participants said the feature on the t:slim X2 insulin pump was easy to use.2

71%

Average time in range‡ per day spent by Control-IQ technology study participants, versus 59% with sensor augmented pump.1

Stacy with t:slim X2 Insulin Pump

Proven results with Control-IQ technology

In a six-month study that was funded by the National Institute of Health, participants completed a technology acceptance survey. Based on a five-point scale, they rated the t:slim X2™ with Control-IQ technology™ with a 4.8 desire to keep using, 4.7 for ease of use, 4.6 for usefulness, and 4.5 for trust.2

See the evidence

Powered by the t:slim X2 insulin pump

One Pump for Many People

The t:slim X2 insulin pump can be used with or without continuous glucose monitoring (CGM, sold separately). For your people who do use CGM, you can also recommend either Control-IQ technology or Basal-IQ™ technology for automated insulin dosing.

Easy to Learn, Easy to Teach

Like all Tandem Diabetes Care® products, Control-IQ technology is easy to use, learn, and teach. Our predictive technologies integrate with the t:slim X2 insulin pump so people won't need to learn an entirely new system.

Online Access to Pump Data

Through your diabetes management web application, you can upload, view, and print pump data from a single user-friendly webpage accessible from any internet-connected computer, anytime, anywhere.

t:slim X2 Insulin Pump with Control-IQ Technology

Zero Fingersticks

The t:slim X2 insulin pump integrates with the Dexcom G6 CGM and does not require fingersticks for calibration or mealtime dosing.†

Learn More

 
† If glucose alerts and Dexcom G6 CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

Getting started is fast and easy with
Tandem resources for healthcare professionals

Research

Review clinical study outcomes and compare product specs.

Information

Get people started

Find all the information you need to help get your users started on Tandem products.

Recommend

Train

Train anywhere with our online tutorials.

Training

Webinar

T1D and Mental Health Support for Your Patients

If you missed the live webinar with Dr. Mark Heyman, Diabetes Psychologist and Certified Diabetes Care Education Specialist, you can now watch the replay. A recording of Dr. Heyman’s presentation, “T1D and Mental Health: Management Strategies to Help Support Patients,” is now available online. In this webinar, Dr. Heyman discusses the importance of understanding mental health concerns when it comes to T1D care and shares diabetes management strategies to help support your patients.
Watch The Webinar

Request to be Contacted

If you are a clinician and want to learn more about our products, please fill out this form and a representative will contact you. If you are a Tandem pump user, please contact Tandem.

All form fields are required. By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. We respect and uphold the confidentiality of your personal information, and will not share your information with any third parties, except as noted in our privacy policy. A link to our privacy policy is available at the bottom of this page.

Responsible Use of Basal-IQ technology and Control-IQ technology

Systems like the t:slim X2 insulin pump with Basal-IQ technology and the t:slim X2 insulin pump with Control-IQ technology are not substitutes for active diabetes management. For example, users still must bolus for meals. Basal-IQ technology is designed to predict and help prevent lows, but it cannot prevent all lows and Basal-IQ technology does not predict high glucose events. Control-IQ technology is designed to predict and help prevent low and high glucose events, but it cannot prevent all highs and lows, and Control-IQ requires that users accurately input information, such as meals and periods of sleep or exercise. The Basal-IQ and Control-IQ features rely on continuous CGM readings and will not be able to predict glucose levels and adjust insulin dosing if the CGM is not working properly or is unable to communicate with the pump. Users must be sure to always use their pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Users should always pay attention to their symptoms, actively monitor and manage glucose levels, and treat according to prescriber recommendations.

*If glucose values are predicted to be above 10.0 mmol/L, Control-IQ technology calculates a correction bolus using the  Personal Profile settings and a target of 6.1 mmol/L and delivers 60% of that value. It will do this up to once per hour as needed.
†If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Dexcom G6 CGM sold separately.
‡ As measured by CGM.

References:
1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019;381(18):1707-17. DOI: 10.1056/NEJMoa1907863
2. Brown SA. Clinical acceptance of the artificial pancreas: Glycemia outcomes from a 6-month multicenter RCT. Poster presented at 79th Scientific Sessions of the American Diabetes Association; June 7-11, 2019; San Francisco, CA.

Important Safety Information

The pump and each System below is indicated for use in individuals six years of age and greater. The pump and each System is intended for single user use. The pump and each System is indicated for use with NovoRapid, Admelog, or Humalog U-100 insulin.

The t:slim X2 insulin pump with Basal-IQ technology (the Basal-IQ System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Basal-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings.

The t:slim X2 insulin pump with Control-IQ technology (the Control-IQ System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Control-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Control-IQ technology can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The t:slim X2 insulin pump with Control-IQ technology can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The t:slim X2 insulin pump with Control-IQ technology is intended for the management of Type 1 diabetes.

Warnings:

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

 
Do not use the t:slim X2 insulin pump with Control-IQ technology if using hydroxyurea. Neither System is indicated for use in pregnant women, people on dialysis, or critically ill users. Users of the pump and either System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.